Skip to main content

Forum on Drug Discovery, Development, and Translation 2015 Annual Report (2016) / Chapter Skim
Currently Skimming:

Looking Forward: Forum Activities in 2016
Pages 12-15

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 12...
... Mapping and Connecting the Biomedical Innovation Ecosystem -- Action Collaborative In 2016, a priority-setting tool developed from the Mapping initiative will be piloted and improved, and Forum meetings will provide opportunities for information sharing about key bottlenecks and science policy priorities in the biomedical innovation ecosystem. Clinical Trial Site Standards Harmonization -- Action Collaborative Collaborative participants have undertaken a second phase of the collaborative activity, which includes the collection, analysis, and assessment of how clinical trial site standards October 29 August 5–6 Discussion Series: Administrative and April 29–30 Discussion Series: Conflict of Regulatory Inefficiencies in Clinical Forum Meeting #15 Interest (Forum Meeting #16)
Read the entire page →
From page 13...
... Russ Altman discusses the Mapping and Connecting the Biomedical Innovation Ecosystem flowchart during the June 2015 meeting of the Forum. March 29–30 July 12 Workshop: Advancing South Africa Workshop Summary Regulatory Science for Medical June 27–28 Report Release: The Emerging Countermeasure Development Workshop: Public Engagement Threat of Multidrug-Resistant (in collaboration with the Medical and Clinical Trials: New Models Tuberculosis: Global and Local Preparedness Forum)
Read the entire page →
From page 14...
... Several large cohort studies have incorporated or begun to incorporate genetic data collection as part of the study design. With the large volumes of genetic and phenotypic data that are planned to be collected, these November 7–8 Workshop: Envisioning a Transformed October 4–5 Clinical Trials Enterprise in the United March 13–14 Forum Meeting #20 States: Establishing an Agenda for 2020 Forum Meeting #21 2012 September 20–21 November 15 Workshop: Strengthening a Workforce for Innovative Russia Workshop Summary Report Release: The New Profile Regulatory Science in Therapeutics Development of Drug-Resistant Tuberculosis: A Global and Local Perspective
Read the entire page →
From page 15...
... The workshop will assess the current landscape of genomic-enabled drug discovery and development activities; examine how to enable partnerships and develop better business models; and consider gaps and best practices in how data from popula tions could be collected with the goal of improving the drug discovery process. June 4–5 October 4–5 November 26–27 Workshop: Maximizing the Goals of Workshop: Sharing Clinical Research Data Workshop: Large Simple Trials and Knowledge the Cures Acceleration Network to (in collaboration with the Neuroscience Generation in a Learning Health System Accelerate the Development of New Forum, National Cancer Policy Forum, (in collaboration with the Roundtable on Drugs and Diagnostics and Genomics Roundtable)
Read the entire page →

Key Terms

  • drug development
  • clinical trial
  • biomedical innovation
  • forum meetings
  • drug discovery

  • sharing clinical
  • workshop summary
  • site standards
  • innovation ecosystem
  • south africa

  • trial site
  • policy forum
  • collaborative collaborative
  • genetic data
  • clinical trials

  • deriving drug
  • clinical success
  • information sharing
  • drug approvals
  • action collaborative

  • pharmaceutical companies
  • create efficiencies
  • emerging threat
  • acceleration network
  • ecosystem flowchart

  • simple trials
  • therapeutics development
  • cures acceleration
  • study design
  • trials enterprise


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.